IL220517A - Stable non-water storage preparation for use through the skin containing solvent and derivative or vitamin D analogue - Google Patents

Stable non-water storage preparation for use through the skin containing solvent and derivative or vitamin D analogue

Info

Publication number
IL220517A
IL220517A IL220517A IL22051712A IL220517A IL 220517 A IL220517 A IL 220517A IL 220517 A IL220517 A IL 220517A IL 22051712 A IL22051712 A IL 22051712A IL 220517 A IL220517 A IL 220517A
Authority
IL
Israel
Prior art keywords
analogue
vitamin
solvents
derivative
topical composition
Prior art date
Application number
IL220517A
Other languages
English (en)
Hebrew (he)
Other versions
IL220517A0 (en
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of IL220517A0 publication Critical patent/IL220517A0/en
Publication of IL220517A publication Critical patent/IL220517A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL220517A 2009-12-22 2012-06-19 Stable non-water storage preparation for use through the skin containing solvent and derivative or vitamin D analogue IL220517A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK2009000264 2009-12-22
US29310810P 2010-01-07 2010-01-07
PCT/DK2010/000184 WO2011076209A2 (en) 2009-12-22 2010-12-22 Pharmaceutical composition comprising solvent mixture and a vitamin d derivative or analogue

Publications (2)

Publication Number Publication Date
IL220517A0 IL220517A0 (en) 2012-08-30
IL220517A true IL220517A (en) 2016-08-31

Family

ID=43618136

Family Applications (1)

Application Number Title Priority Date Filing Date
IL220517A IL220517A (en) 2009-12-22 2012-06-19 Stable non-water storage preparation for use through the skin containing solvent and derivative or vitamin D analogue

Country Status (14)

Country Link
US (1) US20130023501A1 (cg-RX-API-DMAC7.html)
EP (1) EP2515866B1 (cg-RX-API-DMAC7.html)
JP (1) JP5732471B2 (cg-RX-API-DMAC7.html)
CN (1) CN102770121B (cg-RX-API-DMAC7.html)
AU (1) AU2010335656B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012015437A2 (cg-RX-API-DMAC7.html)
CA (1) CA2785254A1 (cg-RX-API-DMAC7.html)
ES (1) ES2452872T3 (cg-RX-API-DMAC7.html)
IL (1) IL220517A (cg-RX-API-DMAC7.html)
MX (1) MX2012007225A (cg-RX-API-DMAC7.html)
NZ (1) NZ601001A (cg-RX-API-DMAC7.html)
RU (1) RU2559084C2 (cg-RX-API-DMAC7.html)
WO (1) WO2011076209A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201204622B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2902282C (en) * 2013-02-27 2023-03-14 Laurie Robert BATT Transdermal formulations
KR102486797B1 (ko) * 2016-03-09 2023-01-11 삼성전자 주식회사 전자 장치 및 전자 장치의 디스플레이 구동 방법
CN107643354B (zh) * 2016-07-22 2022-02-01 重庆华邦胜凯制药有限公司 卡泊三醇起始原料a及相关杂质的分离与测定方法
CN106265511A (zh) * 2016-08-22 2017-01-04 江苏知原药业有限公司 一种性能优异的卡泊三醇倍他米松自微乳制剂
CN106265485A (zh) * 2016-08-22 2017-01-04 江苏知原药业有限公司 一种稳定性改善的卡泊三醇组合物
CN108904445A (zh) * 2018-08-06 2018-11-30 江苏知原药业有限公司 钙泊三醇纳米悬浮液
CA3157812C (en) * 2019-10-25 2024-10-22 Cardiol Therapeutics Inc. CANNABIDIOL COMPOSITIONS INTENDED FOR USE IN THE TREATMENT OF HEART CONDITIONS
KR102891680B1 (ko) 2020-07-28 2025-11-27 아큐티스 바이오테라퓨틱스, 인크. Jak 저해제 및 라우레스-4를 함유하는 국소 제형
WO2023114832A1 (en) 2021-12-15 2023-06-22 Arcutis Biotherapeutics, Inc. Stable formulations of shr0302

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4083974A (en) * 1977-03-07 1978-04-11 The Upjohn Company Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
DE4011682A1 (de) * 1990-04-06 1991-10-10 Schering Ag 24-oxa-derivate in der vitamin d-reihe
US5194431A (en) * 1992-07-08 1993-03-16 Wisconsin Alumni Research Foundation 24-cyclopropane vitamin D derivatives
USRE39706E1 (en) 1993-01-15 2007-06-26 Leo Pharma A/S Crystalline form of a vitamin D analogue
GB9611603D0 (en) * 1996-06-04 1996-08-07 Leo Pharm Prod Ltd Chemical compounds
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
PT2915534T (pt) * 1999-04-23 2018-06-20 Leo Pharma As Composição farmacêutica para aplicação dérmica para uso no tratamento da psoríase compreendendo vitamina d e um corticosteroide
AU2002363959B2 (en) * 2001-12-03 2007-12-13 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
DE602004027504D1 (de) 2003-07-24 2010-07-15 Leo Pharma As Aminobenzophenonverbindungen
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
FR2871694B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
CA2590479A1 (en) 2004-12-13 2006-06-22 Leo Pharma A/S Triazole substituted aminobenzophenone compounds
FR2887150B1 (fr) * 2005-06-17 2007-08-03 Galderma Res & Dev Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise
FR2909284B1 (fr) * 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
US8148537B2 (en) 2006-12-22 2012-04-03 Leo Pharma A/S Substituted acetophenones useful as PDE4 inhibitors
MY150075A (en) 2007-02-28 2013-11-29 Leo Pharma As Novel phosphodiesterase inhibitors
US7909624B2 (en) 2007-03-26 2011-03-22 Belkin International, Inc. Carabiner universal serial bus hub
EP2146703A1 (en) 2007-04-19 2010-01-27 Leo Pharma A/S Src family kinase inhibitors
WO2008134512A1 (en) * 2007-04-25 2008-11-06 Cytochroma Inc. Oral controlled release compositions comprising vitamin d compound and waxy carrier
EP2146780A1 (en) 2007-05-11 2010-01-27 Sonneborn Inc. Petrolatums having silicone-like properties
HRP20160488T1 (hr) 2008-12-19 2016-06-17 Leo Pharma A/S Triazolopiridini kao inhibitori fosfodiesteraze za liječenje kožnih bolesti

Also Published As

Publication number Publication date
RU2012130411A (ru) 2014-01-27
CN102770121B (zh) 2014-10-15
EP2515866A2 (en) 2012-10-31
NZ601001A (en) 2014-07-25
HK1177696A1 (en) 2013-08-30
MX2012007225A (es) 2012-07-30
AU2010335656B2 (en) 2015-05-07
BR112012015437A2 (pt) 2016-03-15
JP2013515020A (ja) 2013-05-02
IL220517A0 (en) 2012-08-30
ES2452872T3 (es) 2014-04-03
WO2011076209A3 (en) 2012-02-23
US20130023501A1 (en) 2013-01-24
CA2785254A1 (en) 2011-06-30
CN102770121A (zh) 2012-11-07
AU2010335656A1 (en) 2012-07-19
RU2559084C2 (ru) 2015-08-10
EP2515866B1 (en) 2014-02-19
WO2011076209A2 (en) 2011-06-30
JP5732471B2 (ja) 2015-06-10
ZA201204622B (en) 2013-09-25

Similar Documents

Publication Publication Date Title
IL220517A (en) Stable non-water storage preparation for use through the skin containing solvent and derivative or vitamin D analogue
TWI367110B (en) Topical pharmaceutical formulation
EP2313074A4 (en) TOPICAL COMPOSITIONS CONTAINING ISONICOTINAMIDE
GB0709513D0 (en) Topical formulations
ZA201108618B (en) Stable topical compositions for 1,2,4-thiadiazole derivatives
GB0913255D0 (en) Topical composition
IL215360A0 (en) A topical parasiticide composition and uses thereof
EP2473161A4 (en) TOPICAL FORMULATIONS WITH A STEROID
ZA201207839B (en) Pharmaceutical composition comprising a pyrimidineone derivative
SI2344130T1 (sl) Farmacevtski topični sestavki
PL2624699T3 (pl) Kompozycja grzybobójcza zawierająca pochodną tetrazolilooksymu i pochodną tiazolilopiperydyny
GB0921686D0 (en) Topical formulation
GB2464449B (en) A topical ectoparasticide composition
GB0804270D0 (en) Duloxetine formulation
ZA201005683B (en) Topical antimicrobial compositions
EP2433631A4 (en) ANTI-INFLAMMATORY COMPOSITION CONTAINING MACROLACTIN A AND DERIVATIVE THEREOF AS ACTIVE INGREDIENTS
PL394605A1 (pl) Trwała złożona kompozycja farmaceutyczna
EP2303279A4 (en) TOPICAL STEROIDAL FORMULATIONS
EP2124938A4 (en) TOPICAL FORMULATION
GB0808479D0 (en) Topical compositions
EP2310022A4 (en) TOPIC MEDICINE
GB0803376D0 (en) A topical composition
ZA201208949B (en) Topical pharmaceutical composition comprising heparin
ZA201302506B (en) A stable sunscreen composition
GB0808196D0 (en) Topical composition

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees